Literature DB >> 33928583

Cell-Penetrating Peptides Delivering siRNAs: An Overview.

Luca Falato1, Maxime Gestin2, Ülo Langel2,3.   

Abstract

Cell-Penetrating Peptides (CPP) are valuable tools capable of crossing the plasma membrane to deliver therapeutic cargo inside cells. Small interfering RNAs (siRNA) are double-stranded RNA molecules capable of silencing the expression of a specific protein triggering the RNA interference (RNAi) pathway, but they are unable to cross the plasma membrane and have a short half-life in the bloodstream. In this overview, we assessed the many different approaches used and developed in the last two decades to deliver siRNA through the plasma membrane through different CPPs sorted according to three different loading strategies: covalent conjugation, complex formation, and CPP-decorated (functionalized) nanocomplexes. Each of these strategies has pros and cons, but it appears the latter two are the most commonly reported and emerging as the most promising strategies due to their simplicity of synthesis, use, and versatility. Recent progress with siRNA delivered by CPPs seems to focus on targeted delivery to reduce side effects and amount of drugs used, and it appears to be among the most promising use for CPPs in future clinical applications.

Keywords:  Cell-penetrating peptide; Drug delivery system; Multifunctional nanocomplex; Nanotechnology; Small interference RNA

Year:  2021        PMID: 33928583     DOI: 10.1007/978-1-0716-1298-9_18

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  119 in total

Review 1.  Cell-penetrating peptides: classes, origin, and current landscape.

Authors:  Francesca Milletti
Journal:  Drug Discov Today       Date:  2012-03-23       Impact factor: 7.851

Review 2.  Cell-permeable, mitochondrial-targeted, peptide antioxidants.

Authors:  Hazel H Szeto
Journal:  AAPS J       Date:  2006-04-21       Impact factor: 4.009

3.  Enhancement of siRNA transfection by the optimization of fatty acid length and histidine content in the CPP.

Authors:  Ly Porosk; Piret Arukuusk; Kaisa Põhako; Kaido Kurrikoff; Kristina Kiisholts; Kärt Padari; Margus Pooga; Ülo Langel
Journal:  Biomater Sci       Date:  2019-09-24       Impact factor: 6.843

4.  An l- to d-Amino Acid Conversion in an Endosomolytic Analog of the Cell-penetrating Peptide TAT Influences Proteolytic Stability, Endocytic Uptake, and Endosomal Escape.

Authors:  Kristina Najjar; Alfredo Erazo-Oliveras; Dakota J Brock; Ting-Yi Wang; Jean-Philippe Pellois
Journal:  J Biol Chem       Date:  2016-12-06       Impact factor: 5.157

Review 5.  Cell penetrating peptides: A concise review with emphasis on biomedical applications.

Authors:  Hossein Derakhshankhah; Samira Jafari
Journal:  Biomed Pharmacother       Date:  2018-09-28       Impact factor: 6.529

6.  Fatty acid modified octa-arginine for delivery of siRNA.

Authors:  Yuhuan Li; Yujing Li; Xinmei Wang; Robert J Lee; Lesheng Teng
Journal:  Int J Pharm       Date:  2015-09-16       Impact factor: 5.875

7.  Cell-permeable peptide antioxidants targeted to inner mitochondrial membrane inhibit mitochondrial swelling, oxidative cell death, and reperfusion injury.

Authors:  Kesheng Zhao; Guo-Min Zhao; Dunli Wu; Yi Soong; Alex V Birk; Peter W Schiller; Hazel H Szeto
Journal:  J Biol Chem       Date:  2004-06-02       Impact factor: 5.157

8.  PepFect 14, a novel cell-penetrating peptide for oligonucleotide delivery in solution and as solid formulation.

Authors:  Kariem Ezzat; Samir E L Andaloussi; Eman M Zaghloul; Taavi Lehto; Staffan Lindberg; Pedro M D Moreno; Joana R Viola; Tarek Magdy; Rania Abdo; Peter Guterstam; Rannar Sillard; Suzan M Hammond; Matthew J A Wood; Andrey A Arzumanov; Michael J Gait; C I Edvard Smith; Mattias Hällbrink; Ülo Langel
Journal:  Nucleic Acids Res       Date:  2011-02-23       Impact factor: 16.971

9.  A branched TAT cell-penetrating peptide as a novel delivery carrier for the efficient gene transfection.

Authors:  Chanuk Jeong; Jisang Yoo; DaeYong Lee; Yeu-Chun Kim
Journal:  Biomater Res       Date:  2016-09-07

10.  PEGylated enhanced cell penetrating peptide nanoparticles for lung gene therapy.

Authors:  Gizem Osman; Jason Rodriguez; Sze Yan Chan; Jane Chisholm; Gregg Duncan; Namho Kim; Amanda L Tatler; Kevin M Shakesheff; Justin Hanes; Jung Soo Suk; James E Dixon
Journal:  J Control Release       Date:  2018-07-03       Impact factor: 11.467

View more
  4 in total

1.  BR2 cell penetrating peptide effectively delivers anti-p21Ras scFv to tumor cells with ganglioside expression for therapy of ras-driven tumor.

Authors:  Ting Yu; Yingxian Shi; Xinyan Pan; Qiang Feng; Peng Wang; Shuling Song; Lilin Yang; Julun Yang
Journal:  PLoS One       Date:  2022-06-01       Impact factor: 3.752

2.  Suppression of FGF5 and FGF18 Expression by Cholesterol-Modified siRNAs Promotes Hair Growth in Mice.

Authors:  Jungang Zhao; Haojie Lin; Lusheng Wang; Keke Guo; Rongrong Jing; Xuenan Li; Yu Chen; Zhenlin Hu; Shuang Gao; Nuo Xu
Journal:  Front Pharmacol       Date:  2021-07-07       Impact factor: 5.810

3.  Photoactivatable nanoCRISPR/Cas9 System Based on crRNA Reversibly Immobilized on Carbon Nanoparticles.

Authors:  Olga Semikolenova; Lubov Sakovina; Elizaveta Akhmetova; Daria Kim; Ivan Vokhtantsev; Victor Golyshev; Mariya Vorobyeva; Sergey Novopashin; Darya Novopashina
Journal:  Int J Mol Sci       Date:  2021-10-09       Impact factor: 5.923

4.  siRNA delivery using intelligent chitosan-capped mesoporous silica nanoparticles for overcoming multidrug resistance in malignant carcinoma cells.

Authors:  Razieh Heidari; Pegah Khosravian; Seyed Abbas Mirzaei; Fatemeh Elahian
Journal:  Sci Rep       Date:  2021-10-15       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.